Our analysis revealed that SLC16A1 expression was significantly higher in various cancers, including ACC, CESE, CESC, COAD, DLBC, ESCA, GBM, HNSC, KIRC, KICH, LGG, TGCT, SKCM, LIHC, LUSC, OV, PAAD, READ, STAD, and THYM, compared to their respective normal tissues. The gene discussed is SLC16A1; the disease is cancer.